Composition of Certain Condensed Consolidated Financial Statement Line Items (Tables)
|
9 Months Ended |
Sep. 30, 2026 |
|---|
| Organization, Consolidation and Presentation of Financial Statements [Abstract] |
|
| Schedule of Property and Equipment, Net |
Property and equipment consisted of the following: | | | | | | | | | | | | | (in thousands) | September 30,
2026 | | December 31,
2025 | | Laboratory equipment | $ | 6,825 | | | $ | 6,531 | | | Leasehold improvements | 63 | | | 118 | | | Computer hardware | 597 | | | 542 | | | Furniture, fixtures and office equipment | 316 | | | 322 | | | Prototype equipment | 2,330 | | | 2,258 | | | Construction in progress | 4,022 | | | 1,807 | | | 14,153 | | | 11,578 | | | Less: Accumulated depreciation | (8,885) | | | (8,121) | | | Total | $ | 5,268 | | | $ | 3,457 | |
|
| Schedule of Accrued Expenses |
Accrued expenses and other liabilities consisted of the following: | | | | | | | | | | | | | (in thousands) | September 30,
2026 | | December 31,
2025 | | Employee compensation | $ | 2,397 | | | $ | 2,514 | | Accrued research and development | 641 | | | 221 | | Accrued professional and consulting fees | 424 | | | 259 | | | Grant liabilities | 419 | | | — | | | Other | 478 | | | 183 | | | Total | $ | 4,359 | | | $ | 3,177 | |
|
| Schedule of Other Liabilities |
Accrued expenses and other liabilities consisted of the following: | | | | | | | | | | | | | (in thousands) | September 30,
2026 | | December 31,
2025 | | Employee compensation | $ | 2,397 | | | $ | 2,514 | | Accrued research and development | 641 | | | 221 | | Accrued professional and consulting fees | 424 | | | 259 | | | Grant liabilities | 419 | | | — | | | Other | 478 | | | 183 | | | Total | $ | 4,359 | | | $ | 3,177 | |
|
| Schedule of Cash and Cash Equivalents |
Cash, cash equivalents and restricted cash consisted of the following: | | | | | | | | | | | | | (in thousands) | September 30,
2026 | | December 31,
2025 | | Cash and cash equivalents | $ | 10,467 | | | $ | 12,388 | | | Restricted cash included in other long-term assets (Note 8) | 884 | | | 1,002 | | | Total | $ | 11,351 | | | $ | 13,390 | |
|
| Schedule of Restricted Cash |
Cash, cash equivalents and restricted cash consisted of the following: | | | | | | | | | | | | | (in thousands) | September 30,
2026 | | December 31,
2025 | | Cash and cash equivalents | $ | 10,467 | | | $ | 12,388 | | | Restricted cash included in other long-term assets (Note 8) | 884 | | | 1,002 | | | Total | $ | 11,351 | | | $ | 13,390 | |
|